Artiva Biotherapeutics

ARTV

Insider trades and stock quote 2024-2026

All insider trades at Artiva Biotherapeutics

Subscribe RSS
Date Type Insider Position Ø-Price Volume
7/31/2026 Buy Ra Capital Management, LLC Director $9.9 $247,694
7/29/2026 Buy Ra Capital Management, LLC Director $10.0 $208,032
7/24/2026 Buy Ra Capital Management, LLC Director $10.0 $412,777
7/23/2026 Buy Ra Capital Management, LLC Director $10.0 $596,405
7/22/2026 Buy Ra Capital Management, LLC Director $9.9 $835,351
7/21/2026 Buy Ra Capital Management, LLC Director $9.6 $1,151,558
7/17/2026 Buy Ra Capital Management, LLC Director $9.0 $70,544
7/16/2026 Buy Ra Capital Management, LLC Director $8.9 $1,361,575
7/13/2026 Buy Ra Capital Management, LLC Director $8.9 $116,882
7/10/2026 Buy Ra Capital Management, LLC Director $9.0 $135,465
6/26/2026 Buy Ra Capital Management, LLC Director $9.0 $16,846
6/25/2026 Buy Ra Capital Management, LLC Director $8.9 $275,280
6/16/2026 Buy Ra Capital Management, LLC Director $8.9 $1,110,299
6/15/2026 Buy Ra Capital Management, LLC Director $9.0 $138,572
6/12/2026 Buy Ra Capital Management, LLC Director $8.6 $3,351,033
6/11/2026 Buy Ra Capital Management, LLC Director $7.9 $4,339,268
6/10/2026 Buy Ra Capital Management, LLC Director $7.0 $721
6/9/2026 Buy Ra Capital Management, LLC Director $6.9 $3,310,159
5/19/2026 Sell Aslan, Fred Chief Executive Officer $9.0 $244,253
5/19/2026 Sell Banerjee, Subhashis Chief Medical Officer $9.0 $63,386
5/19/2026 Sell Bush, Jennifer COO, CLO, Compliance Officer $9.0 $79,179
5/19/2026 Sell Horan, Christopher Chief Tech Operations Officer $9.0 $63,073
5/19/2026 Sell Raymon, Heather SVP, Research and Development $9.0 $27,879
5/11/2026 Buy Ra Capital Management, LLC Director $11.5 $74,999,992
5/11/2026 Buy Gc Corp. Ten Percent Owner $11.5 $16,499,992
12/15/2025 Sell Aslan, Fred President and CEO $6.0 $19,122
11/17/2025 Sell Aslan, Fred President and CEO $3.4 $21,522
10/17/2025 Sell Aslan, Fred President and CEO $6.0 $153,000
8/15/2025 Sell Aslan, Fred President and CEO $2.7 $69,579
All information without guarantee! No recommendation/consultation! © U.S. Securities and Exchange Commission (SEC)